Concepedia

Limin Hu

LH

Statistics

Publications

33

Citations

2.3K

H-Index

23

Active since

1998

Affiliations

Tianjin University of Traditional Chinese Medicine(Current)

University of California, San Francisco

Tianjin University

Molecular Oncology (United States)

The University of Texas MD Anderson Cancer Center

Limin Hu is an author at Tianjin University of Traditional Chinese Medicine specializing in medicine, pharmacology, and cell biology.

Top concepts

Publications per year

1998–2022

33

Publications

33

Inhibition of phosphatidylinositol 3'-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models.

Limin Hu, Judith Hofmann, Yiling Lu et al. · PubMed · 2002 · 362 citations

, , +14

Vascular endothelial growth factor-trap decreases tumor burden, inhibits ascites, and causes dramatic vascular remodeling in an ovarian cancer model.

Annette T. Byrne, Leorah Ross, Joceyln Holash et al. · PubMed · 2003 · 312 citations

, , +15

In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002).

Limin Hu, Charles Zaloudek, Gordon B. Mills et al. · PubMed · 2000 · 306 citations

, , +15

Vascular Endothelial Growth Factor Immunoneutralization Plus Paclitaxel Markedly Reduces Tumor Burden and Ascites in Athymic Mouse Model of Ovarian Cancer

Limin Hu, Judith Hofmann, Charles Zaloudek et al. · American Journal Of Pathology · 2002 · 163 citations

, , +10

Vascular Endothelial Growth Factor Trap Combined with Paclitaxel Strikingly Inhibits Tumor and Ascites, Prolonging Survival in a Human Ovarian Cancer Model

Limin Hu, Judith Hofmann, Jocelyn Holash et al. · Clinical Cancer Research · 2005 · 128 citations · Full text

1–5 of 33